SLC5A2 and atrial fibrillation: No significant differences were found between groups regarding the type of AF, symptomatology, therapeutic strategies, or medication use, including ACEIs, ARBs, ARNIs, diuretics, beta-blockers, mineralocorticoids, statins, SGLT2 inhibitors, calcium channel blockers, amiodarone, digoxin, antiplatelet agents, and propafenone.